Daubert and Expert Testimony
Bibliographic Data
| ID | 15747730 |
|---|---|
| Authors | Allison Grady (corresponding author) |
| Year | 2006 |
| Volume | 8 |
| Issue | 2 |
| Pages | 97-100 |
| Publication date | 2006-02-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2006.8.2.hlaw1-0602 |
| PMID | 23228539 |
| OpenAlex | W79231753 |
| Language | EN |
| Citations received | 1 |
In the matter of Daubert v Merrell Dow Pharmaceuticals the Supreme Court was asked to “determine the standard for admitting expert scientific testimony in a federal trial” [1]. Its decision in the case set standards that guide the admissibility of expert medical, as well as scientific, testimony
Epistemology · Expert witness · Federal Rules of Evidence · Political science · Rules of evidence · Scientific evidence · Supreme court · Law · Legal Education and Practice Innovations · Medical Malpractice and Liability Issues · Philosophy · Psychology · Torture, Ethics, and Law
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 1 |